David Muhlestein on the level of risk providers are taking on
August 20, 2018
Andréa Caballero speaks with David Muhlestein, Chief Research Officer at Leavitt Partners, about his latest research titled “Growth of Population-Based Payments is Not Associated With a Decrease in Market-Level Cost Growth, Yet.” They discuss what really dictates good competition within a health care market, the proportion of revenue necessary to make a business case for reforming a delivery system, and what kinds of evaluations are needed to scale and inform the next generation of payment reform programs. In addition to leading Leavitt Partner’s research in the evolving health care landscape, David Muhlestein is an Adjunct Assistant Professor of The Dartmouth Institute (TDI) at the Geisel School of Medicine at Dartmouth College, a Visiting Policy Fellow at the Margolis Center for Health Policy at Duke University, and a Visiting Fellow at the Accountable Care Learning Collaborative.
Join David Muhlestein and CPR’s Program Director, Andréa Caballero, by putting on your Chief Financial Officer hat and diving into the latest research on the provider business case. With the recent growth of accountable care organizations (ACO’s) and population-based payments, employers and other purchasers can use conversations like these to see eye-to-eye with their provider partners.